IOF-ESCEO Pre-Clinical Symposium to be held on April 18 in Rome, Italy

Jan 29 2013

Investigators with an interest in pre-clinical and translational musculoskeletal research are invited to attend the 3rd IOF-ESCEO Pre-Clinical Symposium to be held on April 18, in Rome, Italy.

The Symposium will be held in conjunction with the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) from April 17-20, 2013. This key clinical bone event is held annually by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), http://www.ecceo13-iof.org

The Congress will present more than 700 scientific abstracts and is expected to attract over 5000 delegates from around the world.

Chaired by Anna Teti, Professor of Histology at the University of L'Aquila, L'Aquila, Italy, the half-day IOF-ESCEO Pre-Clinical Symposium features eight invited lectures by well-known researchers in the field:

How do rare genetic diseases contribute to the understanding of common bone diseases?

• The contribution of chondrodysplasias to the understanding of osteoarthritis - Michael Briggs
• The contribution of osteodysplasias to the understanding of osteoporosis - Wim van Hul

How do preclinical studies offer new options for future developments?

• Future molecular therapies for osteoporosis - Lorenz C Hofbauer
• New potential developments using siRNA and small peptides - Anna Teti

How does the skeleton impact muscle cells?

• Vascular calcification - Catherine Shanahan
• Key regulators of muscle-bone unit - Roger Fielding

How does the skeleton contribute to ion metabolism?

• Anion transport mechanisms and diseases - Thomas J Jentsch
• Cation transport mechanisms and diseases - H. van Leeuwen

The 3rd Pre-Clinical Symposium is free of charge to registrants of ESCEO13-IOF, while delegates to the Symposium alone may register for only 150 Euro. With the low registration rate, IOF and ESCEO specifically aim to make the Symposium accessible to young investigators in the field.

Source: International Osteoporosis Foundation